Astellas Pharma Inc. Share Price OTC Markets
Stocks
ALPMY
US04623U1025
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
19:54:22 29/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 16.00 USD | +0.76% |
|
+2.04% | +20.39% |
| Market Cap | 4,506B 28.55B 25.53B 23.52B 21.35B 39.93B 2,720B 40.67B 279B 112B 1,428B 107B 105B | P/E 2027 * |
11.4x | P/E 2028 * | 12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 4,447B 28.18B 25.2B 23.21B 21.07B 39.41B 2,684B 40.13B 275B 110B 1,409B 106B 104B | EV / Sales 2027 * |
1.87x | EV / Sales 2028 * | 1.82x |
| Free-Float |
98.92% | Yield 2027 * |
3.19% | Yield 2028 * | 3.31% |
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| ALPMY | Delayed | |
Deutsche Boerse AG
| YPHA | Delayed |
Last Transcript: Astellas Pharma Inc.
| 1 day | +0.76% | ||
| 1 week | +2.04% | ||
| Current month | +10.57% | ||
| 1 month | +7.02% | ||
| 3 months | +17.22% | ||
| 6 months | +11.03% | ||
| Current year | +20.39% |
| 1 week | 15.52 |  | 16.48 |
| 1 month | 13.48 | | 16.48 |
| Current year | 12.82 | | 17.35 |
| 1 year | 10.05 | | 17.35 |
| 3 years | 8.37 | | 17.35 |
| 5 years | 8.37 | | 18.18 |
| 10 years | 8.37 | | 18.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 64 | 09/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 55 | 31/10/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 09/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 64 | 31/05/2019 |
| Director/Board Member | 59 | 31/05/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.76% | +2.04% | - | - | 28.34B | |
| +6.63% | +8.10% | +67.50% | +145.20% | 1,148B | |
| +1.53% | +6.76% | +47.22% | +89.01% | 652B | |
| +1.68% | +2.10% | +27.80% | +109.31% | 505B | |
| +0.73% | +2.47% | +53.85% | +68.96% | 384B | |
| +3.83% | -2.37% | +68.14% | +42.32% | 348B | |
| +2.38% | +4.27% | +33.81% | +57.95% | 294B | |
| +2.26% | +3.47% | +5.21% | +28.92% | 264B | |
| +1.97% | +5.11% | +57.74% | +76.14% | 244B | |
| +4.03% | +7.84% | +40.49% | +116.14% | 197B | |
| Average | +1.50% | +1.39% | +44.64% | +81.55% | 448.57B | |
| Weighted average by Cap. | +1.15% | +1.50% | +49.58% | +95.97% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,375B 15.05B 13.46B 12.39B 11.25B 21.04B 1,433B 21.43B 147B 58.91B 753B 56.52B 55.32B | 2,213B 14.03B 12.54B 11.55B 10.49B 19.62B 1,336B 19.98B 137B 54.91B 701B 52.69B 51.56B |
| Net income | 378B 2.39B 2.14B 1.97B 1.79B 3.35B 228B 3.41B 23.39B 9.37B 120B 8.99B 8.8B | 346B 2.19B 1.96B 1.81B 1.64B 3.07B 209B 3.12B 21.42B 8.59B 110B 8.24B 8.06B |
| Net Debt | -59.3B -376M -336M -309M -281M -526M -35.8B -535M -3.67B -1.47B -18.79B -1.41B -1.38B | -481B -3.05B -2.72B -2.51B -2.28B -4.26B -290B -4.34B -29.76B -11.93B -152B -11.44B -11.2B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | US$16.00 | +0.76% | 72,103 |
| 28/10/26 | US$15.88 | -0.38% | 68,334 |
| 27/10/26 | US$15.94 | -2.03% | 97,190 |
| 26/10/26 | US$16.27 | +2.01% | 60,038 |
| 23/10/26 | US$15.95 | +1.14% | 95,873 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- ALPMY Stock
Select your edition
All financial news and data tailored to specific country editions
